aid: editas-medicine name: Editas Medicine description: 'Editas Medicine is a clinical-stage genome editing company headquartered in Cambridge, Massachusetts, developing durable, precision CRISPR-based gene editing medicines for people with serious diseases. The company works across in vivo and ex vivo approaches and holds foundational CRISPR/Cas9 and Cas12a intellectual property, advancing a pipeline that has included programs in sickle cell disease, beta-thalassemia and inherited retinal disorders. Editas Medicine trades on Nasdaq under the ticker EDIT and was surfaced in the API Evangelist network as a portfolio company of GV (Google Ventures). As a life-sciences research and therapeutics organization it publishes a corporate and investor-relations web presence rather than a public developer API, so this profile captures its identity, web properties, and probed domain-security posture.' url: https://raw.githubusercontent.com/api-evangelist/editas-medicine/refs/heads/main/apis.yml accessModel: pricing: unknown onboarding: unknown trial: false try_now: false public: false label: Unknown confidence: low source: [] generated: '2026-07-22' method: derived image: https://www.editasmedicine.com/wp-content/themes/sage/dist/images/logo-editas-gray_f449d648.svg x-type: company x-source: vc-portfolio x-backed-by: - gv x-tier: stub x-tier-reason: portfolio-lead specificationVersion: '0.20' created: '2026-07-17' modified: '2026-07-19' tags: - Company - Life Sciences - Biotechnology - Gene Editing - CRISPR - Genomics - Therapeutics - Pharmaceuticals apis: [] maintainers: - FN: Kin Lane email: kin@apievangelist.com - FN: APIs.json email: info@apis.io common: - type: Website url: https://www.editasmedicine.com - type: Blog url: https://ir.editasmedicine.com/news-releases - type: Support url: https://www.editasmedicine.com/contact/ - type: PrivacyPolicy url: https://www.editasmedicine.com/privacy-policy/ - type: TermsOfService url: https://www.editasmedicine.com/terms-of-use/ - type: DomainSecurity url: security/editas-medicine-domain-security.yml x-enrichment: date: '2026-07-19' status: backfilled pass: local-v1 note: backfilled from .gitignore signal + verified work evidence